Pluri (PLUR) Share-based Compensation (QoQ) (2010 - 2025)
Pluri (PLUR) Share-based Compensation (QoQ) (2010 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
| 10 |
Pluri |
21.85 Mn |
22.34 Mn |
86,000.00 |
| Date | Value |
|---|
| Dec 31, 2025 |
-36.52% |
| Sep 30, 2025 |
61.10% |
| Jun 30, 2025 |
152.41% |
| Mar 31, 2025 |
29.69% |
| Dec 31, 2024 |
-54.12% |
| Sep 30, 2024 |
-5.58% |
| Jun 30, 2024 |
437.27% |
| Mar 31, 2024 |
-64.40% |
| Dec 31, 2023 |
-63.04% |
| Sep 30, 2023 |
-19.23% |
| Jun 30, 2023 |
1,748.21% |
| Mar 31, 2023 |
1.82% |
| Dec 31, 2022 |
44.74% |
| Sep 30, 2022 |
-99.56% |
| Jun 30, 2022 |
15,460.71% |
| Mar 31, 2022 |
-18.84% |
| Dec 31, 2021 |
-97.84% |
| Sep 30, 2021 |
-11.10% |
| Jun 30, 2021 |
-25.20% |
| Mar 31, 2021 |
13,797.14% |
